BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 32627306)

  • 41. Development and evaluation of a support program for prostate cancer survivors in Alaska.
    Kelley S; DeCourtney C; Thorsness J
    Int J Circumpolar Health; 2015; 74():28605. PubMed ID: 26612829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defining research and infrastructure priorities for cancer survivorship in Australia: a modified Delphi study.
    Crawford-Williams F; Koczwara B; Chan RJ; Vardy J; Lisy K; Morris J; Iddawela M; Mackay G; Jefford M
    Support Care Cancer; 2022 May; 30(5):3805-3815. PubMed ID: 35031828
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Royal Australian and New Zealand College of Psychiatrists expert consensus statement for the treatment, management and monitoring of the physical health of people with an enduring psychotic illness.
    Lambert TJ; Reavley NJ; Jorm AF; Oakley Browne MA
    Aust N Z J Psychiatry; 2017 Apr; 51(4):322-337. PubMed ID: 28343435
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Not all prostate cancer is the same - patient perceptions: an Asia-Pacific region study.
    Akakura K; Bolton D; Grillo V; Mermod N
    BJU Int; 2020 Sep; 126 Suppl 1():38-45. PubMed ID: 32521568
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Follow-up care after treatment for prostate cancer: evaluation of a supported self-management and remote surveillance programme.
    Frankland J; Brodie H; Cooke D; Foster C; Foster R; Gage H; Jordan J; Mesa-Eguiagaray I; Pickering R; Richardson A
    BMC Cancer; 2019 Apr; 19(1):368. PubMed ID: 31014282
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identifying patients' priorities for quality survivorship: conceptualizing a patient-centered approach to survivorship care.
    Mead KH; Raskin S; Willis A; Arem H; Murtaza S; Charney L; Pratt-Chapman M
    J Cancer Surviv; 2020 Dec; 14(6):939-958. PubMed ID: 32607715
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus.
    Bonet M; González D; Baquedano JE; García E; Altabas M; Casas F; Feltes N; Ferrer F; Foro P; Fuentes R; Galdeano M; Gomez D; Henriquez I; Jové J; Lozano J; Maldonado X; Mases J; Membrive I; Paredes S; Roselló À; Sancho G; Mira M
    Clin Transl Oncol; 2023 Apr; 25(4):1017-1023. PubMed ID: 36436177
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quality Indicators for Global Benchmarking of Localized Prostate Cancer Management.
    Sampurno F; Zheng J; Di Stefano L; Millar JL; Foster C; Fuedea F; Higano C; Hulan H; Mark S; Moore C; Richardson A; Sullivan F; Wenger NS; Wittmann D; Evans S
    J Urol; 2018 Aug; 200(2):319-326. PubMed ID: 29477721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identifying research priorities in eating disorders: A Delphi study building consensus across clinicians, researchers, consumers, and carers in Australia.
    Hart LM; Wade T
    Int J Eat Disord; 2020 Jan; 53(1):31-40. PubMed ID: 31571252
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determinants of patient activation in a community sample of breast and prostate cancer survivors.
    O'Malley D; Dewan AA; Ohman-Strickland PA; Gundersen DA; Miller SM; Hudson SV
    Psychooncology; 2018 Jan; 27(1):132-140. PubMed ID: 28133892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe.
    Vaz-Luis I; Masiero M; Cavaletti G; Cervantes A; Chlebowski RT; Curigliano G; Felip E; Ferreira AR; Ganz PA; Hegarty J; Jeon J; Johansen C; Joly F; Jordan K; Koczwara B; Lagergren P; Lambertini M; Lenihan D; Linardou H; Loprinzi C; Partridge AH; Rauh S; Steindorf K; van der Graaf W; van de Poll-Franse L; Pentheroudakis G; Peters S; Pravettoni G
    Ann Oncol; 2022 Nov; 33(11):1119-1133. PubMed ID: 35963481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. From early detection to rehabilitation in the community: reading beyond the blog testimonies of survivors' quality of life and prostate cancer representation.
    Zanchetta MS; Cognet M; Lam-Kin-Teng MR; Dumitriu ME; Renaud L; Rhéaume J
    Health Qual Life Outcomes; 2016 Dec; 14(1):171. PubMed ID: 27986091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of quality indicators to monitor radiotherapy care for men with prostate cancer: A modified Delphi method.
    Tsiamis E; Millar J; Baxi S; Borg M; De Ieso P; Elsaleh H; Foroudi F; Higgs B; Holt T; Martin J; Moretti K; Pryor D; Skala M; Evans S
    Radiother Oncol; 2018 Aug; 128(2):308-314. PubMed ID: 29753551
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Providing prostate cancer survivorship care in Japan: Implications from the USA care model.
    Osawa T; Wittmann D; Jimbo M; Keller ET; Namiki S; Abe T; Shinohara N; Skolarus TA
    Int J Urol; 2016 Nov; 23(11):906-915. PubMed ID: 27624609
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When a policy decision meets practice realities: The case of cancer survivorship care and rehabilitation needs assessment.
    Handberg C; Thorne S; Maribo T
    Eur J Oncol Nurs; 2018 Apr; 33():70-77. PubMed ID: 29551180
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Unmet needs in breast cancer survivors are common, and multidisciplinary care is underutilised: the Survivorship Needs Assessment Project.
    Vuksanovic D; Sanmugarajah J; Lunn D; Sawhney R; Eu K; Liang R
    Breast Cancer; 2021 Mar; 28(2):289-297. PubMed ID: 32929637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adapting community child and family health service models for rural and other diverse settings: A modified Delphi study to identify key elements.
    Stockton DA; Fowler C; Debono D; Travaglia J
    Health Soc Care Community; 2022 Nov; 30(6):e6145-e6162. PubMed ID: 36195997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Deliberative democracy and cancer screening consent: a randomised control trial of the effect of a community jury on men's knowledge about and intentions to participate in PSA screening.
    Thomas R; Glasziou P; Rychetnik L; Mackenzie G; Gardiner R; Doust J
    BMJ Open; 2014 Dec; 4(12):e005691. PubMed ID: 25539779
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mapping unmet supportive care needs, quality-of-life perceptions and current symptoms in cancer survivors across the Asia-Pacific region: results from the International STEP Study.
    Molassiotis A; Yates P; Li Q; So WKW; Pongthavornkamol K; Pittayapan P; Komatsu H; Thandar M; Yi M; Titus Chacko S; Lopez V; Butcon J; Wyld D; Chan RJ;
    Ann Oncol; 2017 Oct; 28(10):2552-2558. PubMed ID: 28961835
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identifying associations between quality of life outcomes and healthcare-related variables among colorectal cancer survivors: A cross-sectional survey study.
    Drury A; Payne S; Brady AM
    Int J Nurs Stud; 2020 Jan; 101():103434. PubMed ID: 31670170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.